are biological molecules which act as indicator of a particular disease state or pharmacological conditions. Advancement in post genomic technologies, increasing R&D spending and dynamic applications of biomarkers in medicine will drive the future market growth.
The market for Biomarkers is classified into five categories based on types, application areas, therapeutic segments, products and by end users, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biomarkers market.
The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2015 are detailed.
The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.
The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biomarkers market and future opportunities that can propel the market.
The report contains the most detailed and in-depth segmentation and analysis of the Global Biomarkers Market during the forecast period 2015 - 2020.
Sample Companies Profiled in this Report are:
- EKF Diagnostics Holdings plc
- Meso Scale Diagnostics, LLC
- Singulex, Inc.
- BioSims Technologies
- Cisbio Bioassays